Primary Cells Market worth $ 1,107.3 million by 2023 Â– Exclusive Report by MarketsandMarketsÂ™

(IT-NEWSWIRE.COM, March 30, 2020 ) According to research report the report " Primary Cells Market by Type (Human Primary Cells, Animal Primary Cells), Origin (Hematopoietic, Blood, Skin, Gastrointestinal, Hepatocytes, Renal, Skeleton & Muscles), End User (Life Science Research & Research Institutes) - Global Forecast to 2023", The primary cells market is expected to reach USD 1,107.3 million by 2023 from USD 666.0 million in 2017 at a CAGR of 8.5% from 2018–2023.

Access Free Sample Research Copy : https://www.marketsandmarkets.com/requestsampleNew.asp?id=32854960

Factors driving the growth of this market include increasing cancer research, high prevalence of cancer disorders, increasing research funding for the development of new cancer therapies, and increasing number of collaborations & acquisitions.

Hematopoietic cells segment is estimated to account for the largest share of the primary cells market in 2018.

Primary cells are cells isolated from human or animal tissues. These cells are ideal models for cancer biomarker discovery and drug screening. They are also used to understand the biochemical pathways of cellular interactions.

In cancer research, primary cells are often exposed to heavy radiation doses, chemicals, and viruses, which transforms these cells into cancer cells through genetic mutations and the introduction of oncogenes. In this way, the molecular-level mechanism and cause of cancer, as well as the altered signaling pathways of cancerous cells, can be studied.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32854960

The objectives of this study are as follows:

# To define, describe, and forecast the primary cells market by origin, type, end user and region

# To forecast the revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia, and the Rest of the World (RoW)

# To identify micromarkets and the drivers, opportunities, and trends affecting the growth of the market

# To strategically analyze market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall market

# To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders

# To track and analyze competitive developments such as acquisitions; product launches, expansions; and R&D activities in the primary cells market

The global primary cells market is dominated by North America, followed by Europe. North America will continue to dominate the global primary cells market during the forecast period, however, Asia is expected to witness the highest CAGR, with the growth in this market centered on China and Japan.

Get Sample Copy of This Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=32854960

North America is expected to command the largest share of the market during the forecast period.

Based on region, the global primary cells market is segmented into North America, Europe, Asia, and Rest of the World (RoW). North America is estimated to dominate the primary cells market in 2017. This is mainly due to factors such as the increasing research on increasing prevalence of cancer related disorders, and presence of all key players in the region.

Key players in the primary cells market include Thermo Fisher Scientific (US), Merck KGaA (Germany), Lonza (Switzerland), Cell Biologics (US), PromoCell (Germany), ZenBio (US), STEMCELL Technologies (Canada), AllCells (US), American Type Culture Collection (US), and Axol Biosciences (UK).

MarketsandMarkets™

Mr. Sanjay Gupta

1-888-600-6441

raviraj.tak@marketsandmarkets.com

Source: EmailWire.Com

Source: EmailWire.com

Technology News & Search Engine

Primary Cells Market worth $ 1,107.3 million by 2023 Â– Exclusive Report by MarketsandMarketsÂ™